ARCHIVES

NIH Limits Increases In Competing Renewals To Biomedical Deflator

This article is from The Cancer Letter archive.

Vol. 17 No. 35 | August 30, 1991

Download PDF Visit The Full Archive

Related Articles

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

Other DCT Concepts Approved By Board

February 26, 1988

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

In Brief: NCI’s Reorganization Plan Picks Up Speed In New Bureaucracy, Could Be Approved Soon

February 29, 1980

NCI Would Fund 1,052 Competing Grants In Fy95

February 11, 1994

DCPC Advisors Okay New Grant Programs To Improve Participation Of Women, Minorities In Clinical Trials

May 26, 1995